A Phase 1 dose-escalation study of the safety and pharmacokinetics of once-daily oral foretinib, a multi-kinase inhibitor, in patients with solid tumors

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

Medicine, Oncology, Cancer Pharmacology +12

EGFR exon 20 insertion A763-Y764insFQEA and response to erlotinib-letter

National University of Singapore · 2013 · 1.9K citations

Medicine, Molecular Biology, Oncology +14

Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors

Barbara Sennino, Toshina Ishiguro‐Oonuma, Ying Wei et al. · Cancer Discovery · 2012 · 417 citations · Full text

Medicine, Oncology, Pharmacology +17

Hepatocyte Growth Factor Enhances Vascular Endothelial Growth Factor-Induced Angiogenesis in Vitro and in Vivo

Xiaohua Xin, Gladys S. Ingle, Constance Zlot et al. · American Journal Of Pathology · 2001 · 397 citations · Full text

Medicine, Cancer Biology, Hepatology +8

Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation

Yu-Wen Zhang, Yanli Su, Olga V. Volpert et al. · Proceedings of the National Academy of Sciences · 2003 · 343 citations · Full text

Medicine, Cancer Biology, Oncology +15